Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orchestra BioMed Holdings (OBIO) Liabilities and Shareholders Equity: 2022-2024

Historic Liabilities and Shareholders Equity for Orchestra BioMed Holdings (OBIO) over the last 3 years, with Dec 2024 value amounting to $76.2 million.

  • Orchestra BioMed Holdings' Liabilities and Shareholders Equity rose 39.15% to $104.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $282.9 million, marking a year-over-year decrease of 13.11%. This contributed to the annual value of $76.2 million for FY2024, which is 20.00% down from last year.
  • Latest data reveals that Orchestra BioMed Holdings reported Liabilities and Shareholders Equity of $76.2 million as of FY2024, which was down 20.00% from $95.2 million recorded in FY2023.
  • In the past 5 years, Orchestra BioMed Holdings' Liabilities and Shareholders Equity ranged from a high of $95.6 million in FY2022 and a low of $76.2 million during FY2024.
  • Over the past 3 years, Orchestra BioMed Holdings' median Liabilities and Shareholders Equity value was $95.2 million (recorded in 2023), while the average stood at $89.0 million.
  • Data for Orchestra BioMed Holdings' Liabilities and Shareholders Equity shows a maximum YoY dropped of 20.00% (in 2024) over the last 5 years.
  • Yearly analysis of 3 years shows Orchestra BioMed Holdings' Liabilities and Shareholders Equity stood at $95.6 million in 2022, then dropped by 0.38% to $95.2 million in 2023, then decreased by 20.00% to $76.2 million in 2024.